Megan Pace saw first-hand the passion and commitment of the CF community during her tenure at Vertex Pharmaceuticals. She joined the BEF Board in 2015 in order to stay connected with CF patients and families and support the Foundation’s mission. Megan has nearly 20 years of communications, government affairs and strategic planning experience within the biotechnology industry. She currently serves as Chief Corporate Affairs Officer at Moderna Therapeutics. Prior to this, Megan was SVP, Strategic Operations and Communications at Agios Pharmaceuticals; SVP, Corporate Communications at Vertex Pharmaceuticals; and Senior Director, Public Affairs at Genentech.